You have successfully logged out.

Hello !
Logout

Treatment of hydrocephalus

MIETHKE gravitational valves

The critical issue in shunt technology is the posture-dependent hydrostatic pressure change.

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professional before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.
Info graph gravitational valves improve patient outcomes compared to differential pressure valves
Info graph avoid complications
Info graph avoid revisions
Info graph miethke gravitational valves
Info graph benefit from primary implantation
Icons of lying, sitting and standing hydrocephalus patients
Icons of mobile devices, headphones, MRI and toy magnets

MIETHKE M.blue®

You want to know why M.blue® is always the right decision? Learn more about how simple and individual M.blue® works and how it can facilitate your workflow. 
Read more

Together for a better life with hydrocephalus

We have an intensive and longstanding partnership with MIETHKE in the field of neurosurgery. We are driven by a common vision: to improve the lives of hydrocephalus patients with innovative solutions.
Read more about MIETHKE

Related documents

  • MIETHKE Gravitational valves – designed to give you confidence

    Info graph

    pdf, 36.8 KB

  • M.blue® – shunt system for the treatment of hydrocephalus

    Patient manual

    link

[1] Tschan CA, Antes S, Huthmann A, et al. Overcoming CSF overdrainage with the adjustable gravitational valve proSA. Acta Neurochir (Wien) 2014;156(4):767-76; discussion 76.

[2] Sprung C, Schlosser HG, Lemcke J, et al. The adjustable proGAV shunt: a prospective safety and reliability multicenter study. Neurosurgery 2010;66(3):465-74.

[3] Gebert AF, Schulz M, Schwarz K, Thomale UW. Long-term survival rates of gravity-assisted, adjustable differential pressure valves in infants with hydrocephalus. J Neurosurg Pediatr 2016 17:544-551

[4] Lemcke J, Meier U, Müller C, Fritsch M, Kehler U, Langer N et al. Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA). J Neurol Neurosurg Psychiatry 2013 84(8):850-857

[5] Thomale UW, Gebert AF, Haberl H, et al. Shunt survival rates by using the adjustable differential pressure valve combined with a gravitational unit (proGAV) in pediatric neurosurgery. Childs Nerv Syst 2013;29(3):425-31.

[6] Lemcke J, Meier U, Muller C, et al. Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA). J Neurol Neurosurg Psychiatry 2013;84(8):850-7.

[7] Sidambe AT. Biocompatibility of Advanced Manufactured Titanium Implants-A Review. Materials (Basel, Switzerland) 2014;7(12):8168-88.

[8] Saini M, Singh Y, Arora O, et al. Implant biomaterials: A comprehensive review. World journal of clinical cases 2015;3(1):52-7.

[9] Toma AK, Watkins LD. Surgical management of idiopathic normal pressure hydrocephalus: a trial of a trial. Br J Neurosurg 2016;30(6):605.

[10] Toma AK, Stapleton S, Papadopoulos MC, et al. Natural history of idiopathic normal-pressure hydrocephalus. Neurosurg Rev 2011;34(4):433-9.

[11] Irving G, Neves AL, Dambha-Miller H, et al. International variations in primary care physician consultation time: a systematic review of 67 countries. BMJ Open 2017;7(10):e017902.

[12] Suchorska B, Kunz M, Schniepp R, et al. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien) 2015;157(4):703-9.

[13] Chari A, Czosnyka M, Richards HK, Pickard JD, Czosnyka ZH. Hydrocephalus shunt technology: 20 years of experience from the Cambridge Shunt Evaluation Laboratory, J Neurosurg 2014;120(3): 697-707.

[14] Golz L, Lemcke J, Meier U. Indications for valve-pressure adjustments of gravitational assisted valves in patients with idiopathic normal pressure hydrocephalus. Surg Neurol Int. 2013;4:140.

[15]  Xinxing L, Hongyu D, Yunhui L. Using individualized opening pressure to determine the optimal setting of an adjustable proGAV shunt in treatment of hydrocephalus in infants. Childs Nerv Syst. 2015;31(8):1267-71.